Drug Profile

Technetium-99m depreotide - Bayer HealthCare Pharmaceuticals

Alternative Names: Depreotide trifluoroacetate; NeoSpect; NeoTect; P 829; Tc 99m P 829

Latest Information Update: 15 Jun 2015

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Bayer HealthCare Pharmaceuticals
Class Imaging agents; Organotechnetium compounds; Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
Mechanism of Action Image enhancers

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity Yes

Highest Development Phases

Market Withdrawal Lung cancer

Most Recent Events

15 Jun 2015 Withdrawn for Lung cancer (Diagnosis) in Middle East (IV) before June 2015
01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
29 Dec 2006 Schering AG is now called Bayer Schering Pharma AG

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com